GlassScriptPhysician profile
Michael P Lange
NPI 1295748291
$5,647.08
in general payments reported to CMS, 2019-2025
27 companies · $2,285 in 2025
The $2,285 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $475 · 2021: $229 · 2022: $569 · 2023: $699 · 2024: $749 · 2025: $2,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572 · Entertainment: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,571.85 |
| Entertainment | $161.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,327.78 | 2025 | Optilight |
| Alcon Vision LLC | $693.23 | 2019-2025 | Clareon Panoptix Pro, Precision7, Hydrus Microstent |
| Sight Sciences, INC. | $356.80 | 2022-2025 | Omni Surgical System, Tearcare System |
| Biotissue Holdings INC. | $351.29 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $332.57 | 2022-2025 | Infuse, Miebo, Xiidra |
| Abbvie INC. | $266.20 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.68 | 2019-2021 | |
| Allergan, INC. | $184.88 | 2019-2021 | |
| Optos, INC. | $176.23 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $172.23 | 2022-2024 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $155.45 | 2025 | Xdemvy |
| Glaukos Corporation | $151.82 | 2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3, Radius |
| Shire North American Group INC | $148.73 | 2019 | |
| Dompe US, INC. | $132.89 | 2024-2025 | Oxervate |
| Maculogix, INC. | $131.78 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $130.93 | 2019-2024 | Acuvue |
| Abb Con-Cise Optical Group LLC | $125.67 | 2019-2025 | Spectacle Lenses, Contact Lens |
| Notal Vision, INC. | $99.94 | 2024-2025 | Foresee Home |
| Sun Pharmaceutical Industries INC. | $85.07 | 2020-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $83.73 | 2020-2021 | |
| Oyster Point Pharma, INC. | $70.08 | 2023 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $57.77 | 2019-2021 | |
| Lkc Technologies, INC. | $57.03 | 2023 | |
| Ocular Therapeutix, INC. | $52.65 | 2024-2025 | Dextenza |
| Optovue, INC. | $35.00 | 2020 | |
| Aerie Pharmaceuticals, INC. | $29.83 | 2019-2020 | |
| Rxsight INC | $12.82 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.